Work

A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs

Year: 2016

Type: article

Abstract: We present a sarcoma patient with a tumor reduction of more than 50% in lung metastasis after 2 single courses of the investigational medical product Lutathera (Lu-DOTA0-Tyr3-octreotate). She was resistant to more than 6 lines of therapy including all the available active drugs in soft tissue sarcomas. The high expression of somatostatin receptors was shown by microarrays and Octreoscan. The overall duration of response exceeded 1 year.

Source: Clinical Nuclear Medicine

DOI: 10.1097/rlu.0000000000001288

Authors: Aurora Crespo-Jara, Ramón González Manzano, Maribel Lopera Sierra, María Carmen Redal Peña, Antonio Brugarolas Masllorens

Institutions: Hospital Quirón Torrevieja, Universidad Católica de Murcia

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W2467245824

FWCI: 0.462

Cites: 9

Cited by: 13

Related to: 10